EP0301083A4 - Retroviral expression vectors and methods for producing hbv antigens - Google Patents

Retroviral expression vectors and methods for producing hbv antigens

Info

Publication number
EP0301083A4
EP0301083A4 EP19880902298 EP88902298A EP0301083A4 EP 0301083 A4 EP0301083 A4 EP 0301083A4 EP 19880902298 EP19880902298 EP 19880902298 EP 88902298 A EP88902298 A EP 88902298A EP 0301083 A4 EP0301083 A4 EP 0301083A4
Authority
EP
European Patent Office
Prior art keywords
methods
expression vectors
retroviral expression
hbv antigens
producing hbv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19880902298
Other versions
EP0301083A1 (en
Inventor
Alan Mclachlan
David R. Milich
Joseph Sorge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Publication of EP0301083A1 publication Critical patent/EP0301083A1/en
Publication of EP0301083A4 publication Critical patent/EP0301083A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EP19880902298 1987-02-11 1988-02-09 Retroviral expression vectors and methods for producing hbv antigens Withdrawn EP0301083A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1356287A 1987-02-11 1987-02-11
US13562 1987-02-11
US15411788A 1988-02-08 1988-02-08
US154117 1998-09-16

Publications (2)

Publication Number Publication Date
EP0301083A1 EP0301083A1 (en) 1989-02-01
EP0301083A4 true EP0301083A4 (en) 1990-09-26

Family

ID=26684987

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19880902298 Withdrawn EP0301083A4 (en) 1987-02-11 1988-02-09 Retroviral expression vectors and methods for producing hbv antigens

Country Status (4)

Country Link
EP (1) EP0301083A4 (en)
AU (1) AU1391888A (en)
NO (1) NO885658L (en)
WO (1) WO1988006185A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP129A (en) * 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
NZ229260A (en) * 1988-06-03 1994-02-25 Merck & Co Inc Hepatitis b virus, expression cassette for pre-s domain, host cells and
DE69012903T2 (en) * 1989-02-07 1995-05-11 Bio-Technology General Corp., Iselin, N.J. METHOD FOR PRODUCING AND CLEANING HEPATITIS B VACCINE.
DE4107612A1 (en) * 1991-03-09 1992-09-10 Behringwerke Ag RECOMBINANT PROTEINS WITH THE IMMUNE REACTIVITY OF HEPATITIS B VIRUS E ANTIGENS (HBEAG), METHODS FOR THEIR PRODUCTION AND THEIR USE IN IMMUNOASSAYS AND VACCINE SUBSTANCES
US6297048B1 (en) 1992-02-04 2001-10-02 Chiron Corporation Hepatitis therapeutics
ATE219522T1 (en) * 1992-02-04 2002-07-15 Chiron Corp HEPATIST THERAPEUTIC
FR2711670B1 (en) * 1993-10-22 1996-01-12 Pasteur Institut Nucleotide vector, composition containing it and vaccine for immunization against hepatitis.
US6133244A (en) * 1993-10-22 2000-10-17 Institut Pasteur Method for immunization against hepatitis B
US7732423B2 (en) 1994-04-27 2010-06-08 Institut Pasteur Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155198A1 (en) * 1984-02-02 1985-09-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Yeast cloning and expression vectors for a protein in an eucaryotic cell, containing at least a part of a retrovirus genome; transfected eucaryotic cells; process using these cells and obtained proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155198A1 (en) * 1984-02-02 1985-09-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Yeast cloning and expression vectors for a protein in an eucaryotic cell, containing at least a part of a retrovirus genome; transfected eucaryotic cells; process using these cells and obtained proteins

Also Published As

Publication number Publication date
NO885658D0 (en) 1988-12-20
NO885658L (en) 1988-12-20
AU1391888A (en) 1988-09-14
EP0301083A1 (en) 1989-02-01
WO1988006185A1 (en) 1988-08-25

Similar Documents

Publication Publication Date Title
EP0304293A3 (en) Copolyester and process for producing the same
GB2209757B (en) Altered antibodies
NZ221811A (en) Process and intermediate for preparing sucrose-6-acylates
GB2202842B (en) Lightweight refractory and process for producing the same
HUT47974A (en) Process for producing polypeptide
HUT47319A (en) Process for producing bifunctional proteins
HUT46632A (en) Stiff ceramic foam and process for producing same
EP0301083A4 (en) Retroviral expression vectors and methods for producing hbv antigens
IL71953A0 (en) Malaria associated antigen and preparing process thereof
GB8816233D0 (en) Rubella e1 glycoprotein antigens
GR3002158T3 (en) Process for the preparation of naphthacenes
GB8700014D0 (en) Producing copolyester
GB8726230D0 (en) Antibodies
EP0303545A3 (en) Process for the preparation of phenylethanolaminotetralines
ZA88970B (en) Retroviral expression vectors and methods for producing hbv antigens
EP0315906A3 (en) Process for the preparation of ortho-nitrophenetole
IL81339A0 (en) Process for the preparation of 2-tert-butyl-4-methoxy-phenol
CS934887A1 (en) Luminofor bis/4,6 diarylpyridin-2-yl/-arens and process for preparing them
EP0300117A3 (en) Method of preparing cineoles
GB8704665D0 (en) Forming template
CS960887A1 (en) 3-amine-4-hydroxy-/n-phenyl/-benzensulphamide and process for preparing thereof
IL85968A0 (en) Process for the preparation of orthosubstituted arylcarboximido-esters
EG16749A (en) Malaria associated antigen and preparing process thereof
JPS6442459A (en) Improved manufacture of achpa
GB8727834D0 (en) Process for producing antibodies

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17P Request for examination filed

Effective date: 19890208

A4 Supplementary search report drawn up and despatched

Effective date: 19900809

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19901018